Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Meyer

Showing results (451-460 of 510) with videos related to

Pageof 51
Sort By:
Nature Reviews. Clinical Oncology|June 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statementJosep M Llovet, Ezequiel Mauro, Lorenza Rimassa, et al.
Endocrine-Related Cancer|January 5, 2017
Progressive epigenetic dysregulation in neuroendocrine tumour liver metastasesAnna Karpathakis, Harpreet Dibra, Christodoulos Pipinikas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2020
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaRobin Kate Kelley, Tim Meyer, Lorenza Rimassa, et al.
British Journal of Cancer|September 16, 2021
Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK auditAlexa Childs, Nekisa Zakeri, Yuk Ting Ma, et al.
BMJ Open Sport & Exercise Medicine|October 7, 2024
SoccHealth: a health status examination of former professional football (soccer) players within the German National CohortKlaus Berger, Hansjoerg Baurecht, Michael Stein, et al.
Circulation Research|August 21, 2015
Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction ModelJohannes Riegler, Malte Tiburcy, Antje Ebert, et al.
The Oncologist|December 16, 2017
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine TumorsRamon Salazar, Rocio Garcia-Carbonero, Steven K Libutti, et al.
Liver Cancer|May 27, 2026
An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final AnalysisMarkus Peck-Radosavljevic, Akhmed Abdelgafur, Alessandro Granito, et al.
Resuscitation|October 21, 2025
European Resuscitation Council Guidelines 2025 Special Circumstances in ResuscitationCarsten Lott, Vlasios Karageorgos, Cristian Abelairas-Gomez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2015
Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine TumorAnna Karpathakis, Harpreet Dibra, Chistodoulos Pipinikas, et al.
Pageof 51

Showing results (451-460 of 510) with videos related to

Sort By:
Pageof 51
Nature Reviews. Clinical Oncology|June 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statementJosep M Llovet, Ezequiel Mauro, Lorenza Rimassa, et al.
Endocrine-Related Cancer|January 5, 2017
Progressive epigenetic dysregulation in neuroendocrine tumour liver metastasesAnna Karpathakis, Harpreet Dibra, Christodoulos Pipinikas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2020
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaRobin Kate Kelley, Tim Meyer, Lorenza Rimassa, et al.
British Journal of Cancer|September 16, 2021
Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK auditAlexa Childs, Nekisa Zakeri, Yuk Ting Ma, et al.
BMJ Open Sport & Exercise Medicine|October 7, 2024
SoccHealth: a health status examination of former professional football (soccer) players within the German National CohortKlaus Berger, Hansjoerg Baurecht, Michael Stein, et al.
Circulation Research|August 21, 2015
Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction ModelJohannes Riegler, Malte Tiburcy, Antje Ebert, et al.
The Oncologist|December 16, 2017
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine TumorsRamon Salazar, Rocio Garcia-Carbonero, Steven K Libutti, et al.
Liver Cancer|May 27, 2026
An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final AnalysisMarkus Peck-Radosavljevic, Akhmed Abdelgafur, Alessandro Granito, et al.
Resuscitation|October 21, 2025
European Resuscitation Council Guidelines 2025 Special Circumstances in ResuscitationCarsten Lott, Vlasios Karageorgos, Cristian Abelairas-Gomez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2015
Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine TumorAnna Karpathakis, Harpreet Dibra, Chistodoulos Pipinikas, et al.
Pageof 51